article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? In March 2024, FDA therefore approved semaglutide for secondary CVD prevention in overweight or obese adults. Tirzepatide (15 mg) showed slightly more noticeable effects than Semaglutide (2.4

Diabetes 130
article thumbnail

Q&A: Physicians Weigh Improvements in MASLD Treatment Against Gaps in Assessment Strategies

Physician's Weekly

As rates of MASLD, which is linked to obesity and diabetes, rise, new therapies have emerged, but better diagnostic and monitoring strategies are needed. This is a well-done and concise summary of where we are in 2024 in trying to tackle the immense public health problem of MASLD.” PW: What questions remain unanswered for you?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Physicians Foundation Announces New Recipient in Leadership Award Program, Recognized for Addressing Drivers of Health

The Physicians Foundation

is honored for his transformative work, connecting patients with primary care and critical health resources BOSTON, August 15, 2024 – The Physicians Foundation is proud to announce Jubril Oyeyemi, M.D., In July 2024, The Physicians Foundation also honored E. Jubril Oyeyemi, M.D., president of The Physicians Foundation.

article thumbnail

Oregon-based medical group Northwest Permanente announces affiliation with The Permanente Medical Group of Northern California

Permanente Medicine

Both groups have a shared mission of delivering high-quality, cost-efficient care that achieves superior clinical outcomes. By collaborating clinically, sharing innovations, and supporting physicians and staff, NWP will improve quality of care. TPMG teams are sharing programs for diabetes management to support patients in NWP.

Medical 52
article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Eric 15:32 Could do this in clinical practice.

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

ABIM MOC credit will be offered to subscribers in November, 2024. George 03:01 So I would say that as many clinical issues in older adults, we need to think about them in two ways. And we can talk about that later in terms of potential clinical implications that may have code. Eric 11:57 In, let’s say, my clinic.

IT 120
article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.